| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 109.668 | 423.654 | 470.121 | 524.414 | 684.790 |
| Total Income - EUR | - | - | - | - | - | 109.668 | 424.567 | 474.120 | 526.419 | 691.405 |
| Total Expenses - EUR | - | - | - | - | - | 150.577 | 378.320 | 478.573 | 514.522 | 670.483 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -40.909 | 46.248 | -4.453 | 11.896 | 20.922 |
| Net Profit/Loss - EUR | - | - | - | - | - | -41.829 | 42.926 | -8.500 | 6.895 | 15.520 |
| Employees | - | - | - | - | - | 9 | 9 | 9 | 9 | 9 |
Check the financial reports for the company - Primed Medicine Omc S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 132.829 | 215.167 | 306.584 | 256.092 | 214.080 |
| Current Assets | - | - | - | - | - | 18.581 | 36.536 | 13.589 | 28.640 | 32.647 |
| Inventories | - | - | - | - | - | 15.554 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 929 | 4.939 | 5.318 | 20.702 | 11.744 |
| Cash | - | - | - | - | - | 2.098 | 31.598 | 8.271 | 7.938 | 20.903 |
| Shareholders Funds | - | - | - | - | - | -41.767 | 2.086 | -6.407 | 507 | 16.025 |
| Social Capital | - | - | - | - | - | 62 | 61 | 61 | 61 | 60 |
| Debts | - | - | - | - | - | 193.176 | 252.448 | 331.690 | 286.122 | 232.926 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Primed Medicine Omc S.r.l.